Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

计划入组 20 人 · 首次发布于 2024 年 6 月 5 日

Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial

计划入组 30 人 · 首次发布于 2025 年 3 月 3 日

Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use

计划入组 20 人 · 首次发布于 2016 年 5 月 27 日

orexin 1 receptor antagonists (mental disorders)

Dual Orexin OX1/OX2 Receptor Agonists (Orexia)

Orexin 2R NAM program (Addex)

Arvinas Estrogen Receptor, Inc.

United States

NHI-1

United States

Arvinas Androgen Receptor, Inc.

United States

Eolas Therapeutics Assumes Full Development Rights to First-in-Class Orexin-1 Receptor Antagonist AZD4041 for Substance Use Disorders

TheraCryf Advances Orexin-1 Receptor Antagonist for Addiction Treatment with Korean Patent Grant and Manufacturing Milestones

AstraZeneca's AZD4041 Fails in Phase II Trial, Setback for Non-Opioid OUD Treatments